Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

Summary

It is intended to examine the short-term and long-term efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms born at 28 weeks and below. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.

Timeline

Start

2026-04

Primary completion

2027-09

Completion

2029-09

Drugs

Indications